Clinical trial
MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or…
NCT00374049 · Olivera Finn, Other · Completed
Key facts
| NCT number | NCT00374049 |
|---|---|
| Title | MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer |
| Official title | A Pilot Dose Finding Study of MUC1 Vaccine in Conjunction With Poly-ICLC (Polyinosinic-polycytidylic Acid Stabilized With Polylysine and Carboxymethylcellulose) or HiltonolTM in Patients With Recurrent and/or Advanced Prostate Cancer |
| Lead sponsor | Olivera Finn, Other |
| Collaborators | Oncovir, Inc. Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | MUC_1 |
| Enrollment | 14 |
| Start date | Jun 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Dec 1, 2015 |
| First posted | Sep 8, 2006 |
| Last update posted | Jul 12, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: